A Phase 1b multicenter, open-label study evaluating the safety and efficacy of Cannabidiol Oral Solution (CBD-OS) for the treatment of Focal-Onset Seizures.
For more information, please visit: (CT.GOV listing)
.
.
A Phase 1b multicenter, open-label study evaluating the safety and efficacy of Cannabidiol Oral Solution (CBD-OS) for the treatment of Focal-Onset Seizures.
For more information, please visit: (CT.GOV listing)